Study of NS-9 in Patients With Liver Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Liver Neoplasms|Neoplasm Metastasis|Local Neoplasm Recurrences
Interventions: DRUG: NS-9 [Poly I: Poly C]
Sponsor: NS Pharma, Inc.